about
Bioactive factors in uteroplacental and systemic circulation link placental ischemia to generalized vascular dysfunction in hypertensive pregnancy and preeclampsiaHypoxia-inducible factors 1alpha and 2alpha regulate trophoblast differentiation.Peripheral arterial pulse wave analysis in women with pre-eclampsia and gestational hypertension.Human placental microRNAs and preeclampsia.Study of Nitrosative Stress in 'Pregnancy Induced Hypertension'.Gene expression profiling of placentas affected by pre-eclampsiaHypoxia-inducible factor regulates alphavbeta3 integrin cell surface expression.Circulating and Vascular Bioactive Factors during Hypertension in Pregnancy.Parathyroid hormone-related protein in preeclampsia: a linkage between maternal and fetal failures.Circulating microRNA expression profiles in pre-eclampsia: evidence of increased miR-885-5p levels.Increased expression of matrix metalloproteinase-1 in systemic vessels of preeclamptic women: a critical mediator of vascular dysfunction.Effect of Vitamin E on sP-Selectin Levels in Pre-Eclampsia.Shed membrane particles from preeclamptic women generate vascular wall inflammation and blunt vascular contractilityVascular endothelial growth factor in females of reproductive age.Differential effect of intrauterine hypoxia on caspase 3 and DNA fragmentation in fetal guinea pig hearts and brains.Matrix metalloproteinases as drug targets in preeclampsiaMechanisms of Endothelial Dysfunction in Hypertensive Pregnancy and Preeclampsia.Inhibition of nitric oxide synthases abrogates pregnancy-induced uterine vascular expansive remodeling.Placenta-derived angiogenic proteins and their contribution to the pathogenesis of preeclampsia.Plasma factors in severe early-onset preeclampsia do not substantially alter endothelial gene expression in vitro.Diverse mechanisms of endothelium-derived hyperpolarizing factor-mediated dilatation in small myometrial arteries in normal human pregnancy and preeclampsia.Chronic hypoxia opposes pregnancy-induced increase in uterine artery vasodilator response to flow.The mechanism of EDHF-mediated responses in subcutaneous small arteries from healthy pregnant women.Reduced antioxidant capacity in second-trimester pregnancies with pathological uterine perfusion.Bradykinin B1 receptor-mediated vasodilation is impaired in myometrial arteries from women with pre-eclampsia.Reduced uteroplacental perfusion alters uterine arcuate artery function in the pregnant Sprague-Dawley rat.Isoprostanes, prostaglandins and tocopherols in pre-eclampsia, normal pregnancy and non-pregnancy.Matrix Metalloproteinases in Normal Pregnancy and Preeclampsia.Periodontal disease increases the risk of preterm delivery among preeclamptic women.Baroreflex sensitivity, heart rate, and blood pressure variability in hypertensive pregnancy disorders.VEGF expression in the placenta from pregnancies complicated by hypertensive disorders.The effects of magnesium sulfate on placental vascular endothelial growth factor expression in preeclampsia.Altered Endothelial Nitric Oxide Signaling as a Paradigm for Maternal Vascular Maladaptation in Preeclampsia.Association between the soluble epoxide hydrolase gene and preeclampsia.Vascular endothelial growth factor induces endothelin-1 production via matrix metalloproteinase-2 rather than endothelin-converting enzyme-1.Effects of preeclamptic plasma on potassium currents of human umbilical vein endothelial cells.New technologies to reduce medicalization of prenatal care: a contradiction with realistic perspectives.Mechanism of JNK signal regulation by placental HSP70 and HSP90 in endothelial cell during preeclampsia.
P2860
Q28083815-E2ED7151-21A2-440A-8921-9AFFBFE4A1D3Q28585983-8D2CB0CC-9322-40C9-885C-4BA57C6F08F2Q33225180-55238C2B-8A89-4513-9939-72405B089A57Q33581645-E060A329-4773-44D3-BE70-8952E026AE07Q33666195-8B09A722-11A7-4BCC-8DB0-AD4E317C31D4Q33700903-7760EC7A-045A-4C0F-95C4-96490469AF36Q33734575-14AD7594-6740-4743-9A2D-1638D86E0D1DQ33799413-4E17DD9B-C6AD-4967-884E-ECDDF24D8986Q34337529-D444BDEF-6125-485E-91F7-8EB0E62AD19EQ34512770-7C1F6762-AAAC-4D92-9982-3C9C89A1255CQ34760729-48E2607F-5434-4F03-BB1C-D4A4945A24F6Q35022431-2C0334A0-98B4-4F50-BF3D-F9EBD1B7C35BQ35607271-1A2866E1-A001-4421-85BD-8836852710E6Q35678769-E4547A23-8B7B-48D5-A3D1-4C8BB64ACB05Q35931165-F0699223-9F76-425B-82ED-24407578D5C5Q36910638-97AA8D0C-229A-4B38-8648-86C66BF4BA66Q37136212-2CA614E5-6128-4E80-9156-8D73A8EA01B2Q37308497-8FC2D4F9-E6D7-4AFA-B8B1-DB17B5854CD1Q38272641-92635C92-357D-47E9-A505-C8D15BA91013Q38520978-7E5A1787-E976-427A-BD18-B9EFB5BCBEE8Q42976875-C0095E2E-A553-4632-88D6-C3A40B38FAA7Q44217760-93904FD0-1791-4D91-A23E-E8C2EF966FDFQ44748729-8DD4AD9B-42F4-45B6-B507-BB50A535C7E0Q44916177-98ACF033-1853-4F55-ACDD-EA7FAB147D0BQ45001014-09759680-2928-45A7-8FFF-15EA2E6B8DD0Q45163173-7C9100BA-92FF-4954-A03F-F44011F697C8Q45204063-A278AC7D-F7C1-439A-AB9C-F6A11D19C498Q46342648-E79CE4BF-A979-4F2B-A814-D55189DB6623Q46343932-1B00E5FD-27F9-4A23-AAD2-1925F2C591D7Q46346886-08939278-4098-4FB1-A420-3278DCAFEABBQ47339076-641F90CB-FA72-455D-A975-22FF7087ED07Q48002775-C093186B-E421-4F97-BE47-A4376CBB862AQ49887672-6CE5AD2D-0998-416C-B73D-F41134753FD5Q50067730-82D266E4-2E6A-4148-ACB5-DFD8D6E97B45Q53571836-5597F4FE-4714-443E-85EA-B249AAFA0424Q53660798-7E0B720F-3545-499C-9C3B-F710AC1AFF54Q54483132-ADA74DB5-BD15-4EE7-9D5C-FC09D2F0B8E5Q54524128-F9DBFCF1-6A3B-441D-BD61-36E177129DE7
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Vascular function in preeclampsia.
@ast
Vascular function in preeclampsia.
@en
type
label
Vascular function in preeclampsia.
@ast
Vascular function in preeclampsia.
@en
prefLabel
Vascular function in preeclampsia.
@ast
Vascular function in preeclampsia.
@en
P1476
Vascular function in preeclampsia
@en
P2093
P356
10.1016/S0008-6363(00)00087-0
P577
2000-07-01T00:00:00Z